JPRN-UMIN000012175CompletedPhase 2
Phase II trial of Cisplatin and Irinotecan treatment as palliative-intended chemotherapy for previously untreated advanced thymic carcinoma - CDDP/CPT-11 for advanced thymic carcinoma
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital0 sites0 target enrollmentStarted: November 30, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
Study Overview
Brief Summary
o patient was enrolled.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. With concurrent active cancer 2. Serious uncontrolled infections 3. With fever at more than 38 degree in Celicius 4. Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 5. 6. 7. With malignant pleural, peritoneal effusion requiring drainage or pericardial effusion 6. With sever complication associated with operation 7. Under continuous steroid therapy 8. With uncontrolled diabetes melitus 9. With uncontrolled hypertension 10 Unstable angina or previous history of myocardial infarction within six months 11. With interstitial pneumonitis or pulmonary fibrosis detectable on chest X-ray
Investigators
Similar Trials
Completed
Phase 2
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryEsophageal CancerNCT00316862Alliance for Clinical Trials in Oncology82
Completed
Phase 2
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal JunctionGastric AdenocarcinomaStage II Gastric CancerStage III Gastric CancerStage IV Gastric CancerNCT00062374National Cancer Institute (NCI)55
Completed
Phase 2
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractGastrointestinal CancerCarcinoma, NeuroendocrineNCT00353015M.D. Anderson Cancer Center21
Completed
Phase 2
Irinotecan Study For Cervical CancerUterine Cervical NeoplasmsNCT00136955Pfizer41
Terminated
Phase 2
Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine CarcinomaNeuroendocrine CarcinomaNCT03168594Peking University66